Industry: Chemical & Material
Published Date: 2024-04-22
Pages: 87 Pages
Report ld: 3040949
Request Sample
Customized Report
The global Sphingolipids market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Sphingolipids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Sphingolipids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Sphingolipids is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Sphingolipids include CLR Berlin, Evonik Industries AG, Bruker, Calgon Company, Unilever Patent Holdings B.V., Stepan Compan and Procter & Gamble Company, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Sphingolipids production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.
In terms of consumption side, this report focuses on the sales of Sphingolipids by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.
Report Covers:
This report presents an overview of global market for Sphingolipids, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Sphingolipids, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Sphingolipids, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sphingolipids sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Sphingolipids market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Sphingolipids sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including CLR Berlin, Evonik Industries AG, Bruker, Calgon Company, Unilever Patent Holdings B.V., Stepan Compan and Procter & Gamble Company, etc.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sphingolipids production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Sphingolipids in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Sphingolipids manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 9: China by Type, and by Application, sales, and revenue for each segment.
Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sphingolipids sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Sphingolipids Product Introduction
1.2 Market by Type
1.2.1 Global Sphingolipids Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Reagent Grade
1.2.3 Food Grade
1.2.4 Chemical Grade
1.2.5 Other
1.3 Market by Application
1.3.1 Global Sphingolipids Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Skin Care
1.3.3 Hair Care
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Sphingolipids Production
2.1 Global Sphingolipids Production Capacity (2019-2030)
2.2 Global Sphingolipids Production by Region: 2019 VS 2023 VS 2030
2.3 Global Sphingolipids Production by Region
2.3.1 Global Sphingolipids Historic Production by Region (2019-2024)
2.3.2 Global Sphingolipids Forecasted Production by Region (2025-2030)
2.3.3 Global Sphingolipids Production Market Share by Region (2019-2030)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Executive Summary
3.1 Global Sphingolipids Revenue Estimates and Forecasts 2019-2030
3.2 Global Sphingolipids Revenue by Region
3.2.1 Global Sphingolipids Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Sphingolipids Revenue by Region (2019-2024)
3.2.3 Global Sphingolipids Revenue by Region (2025-2030)
3.2.4 Global Sphingolipids Revenue Market Share by Region (2019-2030)
3.3 Global Sphingolipids Sales Estimates and Forecasts 2019-2030
3.4 Global Sphingolipids Sales by Region
3.4.1 Global Sphingolipids Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Sphingolipids Sales by Region (2019-2024)
3.4.3 Global Sphingolipids Sales by Region (2025-2030)
3.4.4 Global Sphingolipids Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (excluding China)
3.9 Middle East, Africa and Latin America
4 Competition by Manufactures
4.1 Global Sphingolipids Sales by Manufacturers
4.1.1 Global Sphingolipids Sales by Manufacturers (2019-2024)
4.1.2 Global Sphingolipids Sales Market Share by Manufacturers (2019-2024)
4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sphingolipids in 2023
4.2 Global Sphingolipids Revenue by Manufacturers
4.2.1 Global Sphingolipids Revenue by Manufacturers (2019-2024)
4.2.2 Global Sphingolipids Revenue Market Share by Manufacturers (2019-2024)
4.2.3 Global Top 10 and Top 5 Companies by Sphingolipids Revenue in 2023
4.3 Global Sphingolipids Sales Price by Manufacturers
4.4 Global Key Players of Sphingolipids, Industry Ranking, 2022 VS 2023 VS 2024
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Sphingolipids Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Key Manufacturers of Sphingolipids, Manufacturing Base Distribution and Headquarters
4.7 Global Key Manufacturers of Sphingolipids, Product Offered and Application
4.8 Global Key Manufacturers of Sphingolipids, Date of Enter into This Industry
4.9 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Sphingolipids Sales by Type
5.1.1 Global Sphingolipids Historical Sales by Type (2019-2024)
5.1.2 Global Sphingolipids Forecasted Sales by Type (2025-2030)
5.1.3 Global Sphingolipids Sales Market Share by Type (2019-2030)
5.2 Global Sphingolipids Revenue by Type
5.2.1 Global Sphingolipids Historical Revenue by Type (2019-2024)
5.2.2 Global Sphingolipids Forecasted Revenue by Type (2025-2030)
5.2.3 Global Sphingolipids Revenue Market Share by Type (2019-2030)
5.3 Global Sphingolipids Price by Type
5.3.1 Global Sphingolipids Price by Type (2019-2024)
5.3.2 Global Sphingolipids Price Forecast by Type (2025-2030)
6 Market Size by Application
6.1 Global Sphingolipids Sales by Application
6.1.1 Global Sphingolipids Historical Sales by Application (2019-2024)
6.1.2 Global Sphingolipids Forecasted Sales by Application (2025-2030)
6.1.3 Global Sphingolipids Sales Market Share by Application (2019-2030)
6.2 Global Sphingolipids Revenue by Application
6.2.1 Global Sphingolipids Historical Revenue by Application (2019-2024)
6.2.2 Global Sphingolipids Forecasted Revenue by Application (2025-2030)
6.2.3 Global Sphingolipids Revenue Market Share by Application (2019-2030)
6.3 Global Sphingolipids Price by Application
6.3.1 Global Sphingolipids Price by Application (2019-2024)
6.3.2 Global Sphingolipids Price Forecast by Application (2025-2030)
7 US & Canada
7.1 US & Canada Sphingolipids Market Size by Type
7.1.1 US & Canada Sphingolipids Sales by Type (2019-2030)
7.1.2 US & Canada Sphingolipids Revenue by Type (2019-2030)
7.2 US & Canada Sphingolipids Market Size by Application
7.2.1 US & Canada Sphingolipids Sales by Application (2019-2030)
7.2.2 US & Canada Sphingolipids Revenue by Application (2019-2030)
7.3 US & Canada Sphingolipids Sales by Country
7.3.1 US & Canada Sphingolipids Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 US & Canada Sphingolipids Sales by Country (2019-2030)
7.3.3 US & Canada Sphingolipids Revenue by Country (2019-2030)
7.3.4 U.S.
7.3.5 Canada
8 Europe
8.1 Europe Sphingolipids Market Size by Type
8.1.1 Europe Sphingolipids Sales by Type (2019-2030)
8.1.2 Europe Sphingolipids Revenue by Type (2019-2030)
8.2 Europe Sphingolipids Market Size by Application
8.2.1 Europe Sphingolipids Sales by Application (2019-2030)
8.2.2 Europe Sphingolipids Revenue by Application (2019-2030)
8.3 Europe Sphingolipids Sales by Country
8.3.1 Europe Sphingolipids Revenue by Country: 2019 VS 2023 VS 2030
8.3.2 Europe Sphingolipids Sales by Country (2019-2030)
8.3.3 Europe Sphingolipids Revenue by Country (2019-2030)
8.3.4 Germany
8.3.5 France
8.3.6 U.K.
8.3.7 Italy
8.3.8 Russia
9 China
9.1 China Sphingolipids Market Size by Type
9.1.1 China Sphingolipids Sales by Type (2019-2030)
9.1.2 China Sphingolipids Revenue by Type (2019-2030)
9.2 China Sphingolipids Market Size by Application
9.2.1 China Sphingolipids Sales by Application (2019-2030)
9.2.2 China Sphingolipids Revenue by Application (2019-2030)
10 Asia (excluding China)
10.1 Asia Sphingolipids Market Size by Type
10.1.1 Asia Sphingolipids Sales by Type (2019-2030)
10.1.2 Asia Sphingolipids Revenue by Type (2019-2030)
10.2 Asia Sphingolipids Market Size by Application
10.2.1 Asia Sphingolipids Sales by Application (2019-2030)
10.2.2 Asia Sphingolipids Revenue by Application (2019-2030)
10.3 Asia Sphingolipids Sales by Region
10.3.1 Asia Sphingolipids Revenue by Region: 2019 VS 2023 VS 2030
10.3.2 Asia Sphingolipids Revenue by Region (2019-2030)
10.3.3 Asia Sphingolipids Sales by Region (2019-2030)
10.3.4 Japan
10.3.5 South Korea
10.3.6 China Taiwan
10.3.7 Southeast Asia
10.3.8 India
11 Middle East, Africa and Latin America
11.1 Middle East, Africa and Latin America Sphingolipids Market Size by Type
11.1.1 Middle East, Africa and Latin America Sphingolipids Sales by Type (2019-2030)
11.1.2 Middle East, Africa and Latin America Sphingolipids Revenue by Type (2019-2030)
11.2 Middle East, Africa and Latin America Sphingolipids Market Size by Application
11.2.1 Middle East, Africa and Latin America Sphingolipids Sales by Application (2019-2030)
11.2.2 Middle East, Africa and Latin America Sphingolipids Revenue by Application (2019-2030)
11.3 Middle East, Africa and Latin America Sphingolipids Sales by Country
11.3.1 Middle East, Africa and Latin America Sphingolipids Revenue by Country: 2019 VS 2023 VS 2030
11.3.2 Middle East, Africa and Latin America Sphingolipids Revenue by Country (2019-2030)
11.3.3 Middle East, Africa and Latin America Sphingolipids Sales by Country (2019-2030)
11.3.4 Brazil
11.3.5 Mexico
11.3.6 Turkey
11.3.7 Israel
11.3.8 GCC Countries
12 Corporate Profiles
12.1 CLR Berlin
12.1.1 CLR Berlin Company Information
12.1.2 CLR Berlin Overview
12.1.3 CLR Berlin Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.1.4 CLR Berlin Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 CLR Berlin Recent Developments
12.2 Evonik Industries AG
12.2.1 Evonik Industries AG Company Information
12.2.2 Evonik Industries AG Overview
12.2.3 Evonik Industries AG Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.2.4 Evonik Industries AG Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Evonik Industries AG Recent Developments
12.3 Bruker
12.3.1 Bruker Company Information
12.3.2 Bruker Overview
12.3.3 Bruker Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.3.4 Bruker Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Bruker Recent Developments
12.4 Calgon Company
12.4.1 Calgon Company Company Information
12.4.2 Calgon Company Overview
12.4.3 Calgon Company Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.4.4 Calgon Company Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Calgon Company Recent Developments
12.5 Unilever Patent Holdings B.V.
12.5.1 Unilever Patent Holdings B.V. Company Information
12.5.2 Unilever Patent Holdings B.V. Overview
12.5.3 Unilever Patent Holdings B.V. Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.5.4 Unilever Patent Holdings B.V. Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Unilever Patent Holdings B.V. Recent Developments
12.6 Stepan Compan
12.6.1 Stepan Compan Company Information
12.6.2 Stepan Compan Overview
12.6.3 Stepan Compan Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.6.4 Stepan Compan Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Stepan Compan Recent Developments
12.7 Procter & Gamble Company
12.7.1 Procter & Gamble Company Company Information
12.7.2 Procter & Gamble Company Overview
12.7.3 Procter & Gamble Company Sphingolipids Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)
12.7.4 Procter & Gamble Company Sphingolipids Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Procter & Gamble Company Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Sphingolipids Industry Chain Analysis
13.2 Sphingolipids Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Sphingolipids Production Mode & Process
13.4 Sphingolipids Sales and Marketing
13.4.1 Sphingolipids Sales Channels
13.4.2 Sphingolipids Distributors
13.5 Sphingolipids Customers
14 Sphingolipids Market Dynamics
14.1 Sphingolipids Industry Trends
14.2 Sphingolipids Market Drivers
14.3 Sphingolipids Market Challenges
14.4 Sphingolipids Market Restraints
15 Key Finding in The Global Sphingolipids Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Sphingolipids was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 132
USD 3950.00
(Single User License)
The global Sphingolipids market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-27
Pages: 128
USD 2900.00
(Single User License)
The global Sphingolipids market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-26
Pages: 137
USD 4900.00
(Single User License)
The global Sphingolipids market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 79
USD 4250.00
(Single User License)
The global market for Sphingolipids was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-24
Pages: 109
USD 3950.00
(Single User License)
The global market for Sphingolipids was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-24
Pages: 94
USD 2900.00
(Single User License)
The global Sphingolipids market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-16
Pages: 89
USD 2900.00
(Single User License)
The global market for Sphingolipids was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 132
The global Sphingolipids market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-27
Pages: 128
The global Sphingolipids market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-26
Pages: 137
The global Sphingolipids market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 79
The global market for Sphingolipids was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-24
Pages: 109
The global market for Sphingolipids was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-24
Pages: 94
The global Sphingolipids market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-16
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now